
Vali oma silt
näidatakse otse viaalilLaboriaruanne
PDF- Testitud
- Dutasteride 1mg × 100 Tabs
- Labor
- Analiza Białek
- Kuupäev
- October 2026
- Tulemus
- 1.02 mg per tablet (1 mg label)
- Tellimuse nr
- Parool
Sõltumatult testitud, kontrollitav parooliga otse laboris.
Dutasteride
Hair & Skin
- Laboris testitud
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
4.6 5-st Trustpilotis73 arvustust
Otsitud ka nimega: Dutasterid
Lühidalt
Dutasteride arvudes
Põhinäitajad meie leksikonist. Lohista punkti mööda kõverat, et näha, kui palju jääb pärast ühte annust arvutuslikult alles.
Täielik leksikoni artikkelHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~5 weeks
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about5weeks
- Class
- 5α-reductase inhibitor type 1 and type 2
- Use
- Oral1 tablet per day or every other day
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexiconDutasteride vs finasteride in androgenetic alopecia (opens in a new tab)
Olsen et al., J Am Acad Dermatol, 2006
Teadmised
Kõik teemal Dutasteride
Üksikasjalik teave tuleb peagi.
Is dutasteride approved?
Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.
How does dutasteride differ from finasteride?
Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.
What do the hair loss trials show?
The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.
What does research show for the prostate?
In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.
Does dutasteride lower prostate cancer risk?
In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.
Which side effects have been described?
In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.
Võrdlused
Kuidas see võrdub
Seotud
Seotud tooted
Snap-8
Peptiidid · Kognitsioon ja uni Kognitsioon ja uni
1 suurus
= 11.6 €/viaal
PTD-DBM
Peptiidid · Vananemisvastane Vananemisvastane
1 suurus
= 56.8 €/viaal
Healthy Hair Skin Nails Blend
Peptiidid · Eritooted ja tugi Eritooted ja tugi
1 suurus
purgi kohta
Finasteride
Ravimid · Hormoonid ja uroloogia Hormoonid ja uroloogia
3 suurust
Dutasteride
